Yoshiaki Fujimori
From Wikipedia, the free encyclopedia
Born1951 (age 74–75)
KnownforCEO, Lixil Group (2011–2016)
Board memberofTakeda Pharmaceutical Company
Boston Scientific
Boston Scientific
Yoshiaki Fujimori | |
|---|---|
![]() | |
| Born | 1951 (age 74–75) |
| Education | University of Tokyo Carnegie Mellon University |
| Known for | CEO, Lixil Group (2011–2016) |
| Board member of | Takeda Pharmaceutical Company Boston Scientific |
Yoshiaki "Fuji" Fujimori (born 1951) is a Japanese businessman. Between August 2011 and June 2016[1] he was the president and CEO of Lixil Group, a Japan headquartered manufacturer of building materials and housing equipment with net sales of $16.8bn,[2] where he oversaw a globalization strategy that included the acquisition of global interests including Permasteelisa, American Standard Brands[3] and GROHE Group.[4] Under his leadership, Lixil expanded its ratio of sales from outside of Japan from 3% in 2010 to 30.3% in 2016.
